iPharma is a global pharmaceutical inhalation contract research organization providing drug discovery, product development, life-cycle management, and product testing from feasibility to commercial inhalation pharmaceutical product services. The company is founded by a team of experts in inhalation product development who learned their skills by developing the newest, most advanced inhalation technologies and products for the US and European regulatory bodies. For early feasibility services, we offer product concept screening, design, and selection on pre-formulation, evaluation of inhalation device delivery options, and drug packaging. As product advances to development phase, we provide more comprehensive services including inhaler and drug formulation development; physical and chemical characterization; stability testing; method development/validation; and product registration. Our product support services will extend through commercialization.